Advancements in Gynecology: A Weekly Review
Ginecologia e Ostetricia
Advances in Cancer Immunotherapy and Obstetric Immunology
This episode explores cutting-edge research in cancer immunotherapy and obstetric immunology, covering resistance mechanisms in PD-1/PD-L1 inhibitors, zinc-based nanoplatforms, homologous recombination deficiency, evolutionary obstetrics, and nutritional care in oncology.
Bibliography
1. Resistance to PD-1/PD-L1 blockade: Mechanism and pharmacological strategies.
Authors: Kim AMJ, Lee N, Chen HY, et al.
Journal: Pharmacological research, 2026 Oct
PMID: 42612932
DOI: 10.1016/j.phrs.2026.108404
2. Prime Editing for Precision Genetic Medicine: A Systematic Review of Technologies, Delivery, and Therapeutic Applications.
Authors: Ruden DM
Journal: Genes, 2026 Sep 17
PMID: 42793032
DOI: 10.3390/genes17091138
3. Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation.
Authors: Wang Y, Wang Y, Zhang C, et al.
Journal: Acta biomaterialia, 2026 Oct
PMID: 42617782
DOI: 10.1016/j.actbio.2026.08.033
4. Maternal mortality, birthweight, and immunogenetics: an evolutionary framework for obstetric risk.
Authors: Ettinghausen L, Moffett A
Journal: American journal of obstetrics and gynecology, 2026 Oct
PMID: 42250788
DOI: 10.1016/j.ajog.2026.06.002
5. The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications.
Authors: Yang Y, Yin Y, Rong S, et al.
Journal: Cancer metastasis reviews, 2026 Sep 23
PMID: 42776262
DOI: 10.1007/s10555-026-10380-9
6. Molecular epidemiology and phylogeographic architecture of oncogenic intracellular bacteria in cervical cancer patients across Northern China.
Authors: Li M, Zhang T, Shen Z, et al.
Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2026 Oct
PMID: 42700938
DOI: 10.1016/j.meegid.2026.106016
7. Women's health initiative strong and healthy silent atrial fibrillation recording study: Rationale, study design, and baseline data.
Authors: Gomez SE, Larson J, Hlatky MA, et al.
Journal: American heart journal, 2026 Oct
PMID: 42107553
DOI: 10.1016/j.ahj.2026.107478
8. Targeting cancer-associated fibroblasts: therapeutic strategies, translational challenges, and future perspectives.
Authors: Jiang Y, Ding B, Yin H, et al.
Journal: Journal of hematology & oncology, 2026 Sep 29
PMID: 42811335
DOI: 10.1186/s13045-026-01845-z
9. Nutritional Status of Patients with Cancer During Oncological Treatment-A Multicenter Cross-Sectional Study.
Authors: Lewandowska A, Lewandowski T, Próchnicki M, et al.
Journal: Nutrients, 2026 Sep 4
PMID: 42739073
DOI: 10.3390/nu18172901
10. CanDo (Canadian Donor Milk) randomised controlled trial: pasteurised human donor milk supplementation in the well-baby unit - protocol.
Authors: Razaghi M, O'Connor DL, Shah J, et al.
Journal: BMJ open, 2026 Sep 15
PMID: 42744366
DOI: 10.1136/bmjopen-2025-114973
Authors: Kim AMJ, Lee N, Chen HY, et al.
Journal: Pharmacological research, 2026 Oct
PMID: 42612932
DOI: 10.1016/j.phrs.2026.108404
2. Prime Editing for Precision Genetic Medicine: A Systematic Review of Technologies, Delivery, and Therapeutic Applications.
Authors: Ruden DM
Journal: Genes, 2026 Sep 17
PMID: 42793032
DOI: 10.3390/genes17091138
3. Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation.
Authors: Wang Y, Wang Y, Zhang C, et al.
Journal: Acta biomaterialia, 2026 Oct
PMID: 42617782
DOI: 10.1016/j.actbio.2026.08.033
4. Maternal mortality, birthweight, and immunogenetics: an evolutionary framework for obstetric risk.
Authors: Ettinghausen L, Moffett A
Journal: American journal of obstetrics and gynecology, 2026 Oct
PMID: 42250788
DOI: 10.1016/j.ajog.2026.06.002
5. The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications.
Authors: Yang Y, Yin Y, Rong S, et al.
Journal: Cancer metastasis reviews, 2026 Sep 23
PMID: 42776262
DOI: 10.1007/s10555-026-10380-9
6. Molecular epidemiology and phylogeographic architecture of oncogenic intracellular bacteria in cervical cancer patients across Northern China.
Authors: Li M, Zhang T, Shen Z, et al.
Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2026 Oct
PMID: 42700938
DOI: 10.1016/j.meegid.2026.106016
7. Women's health initiative strong and healthy silent atrial fibrillation recording study: Rationale, study design, and baseline data.
Authors: Gomez SE, Larson J, Hlatky MA, et al.
Journal: American heart journal, 2026 Oct
PMID: 42107553
DOI: 10.1016/j.ahj.2026.107478
8. Targeting cancer-associated fibroblasts: therapeutic strategies, translational challenges, and future perspectives.
Authors: Jiang Y, Ding B, Yin H, et al.
Journal: Journal of hematology & oncology, 2026 Sep 29
PMID: 42811335
DOI: 10.1186/s13045-026-01845-z
9. Nutritional Status of Patients with Cancer During Oncological Treatment-A Multicenter Cross-Sectional Study.
Authors: Lewandowska A, Lewandowski T, Próchnicki M, et al.
Journal: Nutrients, 2026 Sep 4
PMID: 42739073
DOI: 10.3390/nu18172901
10. CanDo (Canadian Donor Milk) randomised controlled trial: pasteurised human donor milk supplementation in the well-baby unit - protocol.
Authors: Razaghi M, O'Connor DL, Shah J, et al.
Journal: BMJ open, 2026 Sep 15
PMID: 42744366
DOI: 10.1136/bmjopen-2025-114973
